RV Management After LVAD Implantation for Heart Failure

N/A

Waitlist Available

Led By Jonathan Grinstein, MD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Undergoing durable LVAD implantation without plan for perioperative right ventricular mechanical circulatory support

Age ≥ 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through duration of hospitalization, up to 30 days following lvad implantation

Awards & highlights

No Placebo-Only Group

Summary

This trial tests ways to protect the heart's right side when a device to help the left side is implanted.

Who is the study for?

This trial is for adults over 18 who are getting a durable LVAD implant to help their heart pump blood, without needing extra mechanical support for the right side of their heart. It's not for pregnant individuals or those with certain devices already in their heart that they depend on.

What is being tested?

The study is looking at two ways to manage the health of the right ventricle (RV) after an LVAD device has been implanted. One group will receive usual care, while another will follow a standardized RV management plan.

What are the potential side effects?

Since this trial compares different management strategies rather than medications, specific side effects aren't listed like drug trials. However, general risks may include complications from surgery and potential impact on RV function.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am getting a long-term left ventricular assist device without support for the right side of my heart.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through duration of hospitalization, up to 30 days following lvad implantation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through duration of hospitalization, up to 30 days following lvad implantation

This trial's timeline: 3 weeks for screening, Varies for treatment, and through duration of hospitalization, up to 30 days following lvad implantation for reporting.